Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZILUCOPLAN vs ZIMBERELIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZILUCOPLAN vs ZIMBERELIMAB: Safety Overview

Metric ZILUCOPLAN ZIMBERELIMAB
Total FAERS Reports 441 193
Deaths Reported 23 62
Death Rate 5.2% 32.1%
Hospitalizations 163 181
Average Patient Age 58.8 yrs 63.6 yrs
% Female Patients 53.6% 48.3%
FDA Approval Date Oct 17, 2023 N/A
Manufacturer UCB, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A